Tag: EquityResearch
Mankind Pharma Levels Up: ₹12,000 Cr Revenue, ₹8,500 Cr Debt – What’s the Strategy?
Mankind Pharma has crossed a market capitalization of ₹1.05 lakh crore. The company continues to post consistent sales growth, and its EBITDA margins have...
Pharma Sector Technical Setup Indicates Trend Reversal
In April, several stocks from the pharma sector formed hammer candlestick patterns — and that too with high volumes, signaling that buyers were stepping...
Bharti Airtel Ltd: A Global Telecom Giant Evolving into a Digital Powerhouse
Bharti Airtel Ltd – A Global Telecom Leader
Bharti Airtel is one of the world’s leading telecom service providers, with a presence in 18 countries...
MTAR Technologies: Rising Costs, Falling Profits, and Promoter Exit – Time to Reassess?
MTAR Technologies har quarter naye bade targets announce karti hai – ₹700 Cr+ revenue, 28% EBITDA margin, aur clean energy + aerospace sector mein...
HUL: Sleeping Giant Ready to Break Out?
📈 Equity Research Update: Hindustan Unilever Ltd (HUL)
Over the past 2–3 years, HUL’s stock has been consolidating in a sideways trend, but recent management...
Pharma Sector Financial Overview
📊 Pharma Sector Financial Overview: Key Insights from the Latest Report 💊
🔹 Fixed Assets & Borrowings – How are capital investments and leverage impacting...
